Abstract:There are two major reasons to diagnose asymptomatic HIV infection: to facilitate timely initiation of antiretroviral therapy, and to reduce the chance of onward transmission. A negative test offers an opportunity for preventive health promotion. All these aspects of testing require follow up by suitably trained personnel. We describe a case illustrating the hazards of self testing for HIV. A 31 year old British heterosexual man attended the genitourinary medicine clinic requesting an HIV test. His last sexual contact was 3 weeks earlier with a female partner of 3 months. He had recently learnt that she had had a previous male partner who had had African sexual partners and therefore may be at higher risk of having HIV infection. He obtained a home HIV test kit (‘‘Discreet’’ HIV Home Test Kit, Seville Marketing Ltd) from a Canadian based internet site and this result was positive. On further inquiry he gave a history of sore throat and swollen cervical lymph nodes 2 months previously, although these symptoms had largely resolved. He had never tested for HIV before and had no other significant risk factors. We requested an HIV test on the patient; the result was negative. We repeated the test after 3 months and again it was negative, confirming that the patient was not infected at the time he performed the home HIV test. The current HIV screening test used by our centre uses both HIV antibody and p24 antigen detection and is known to detect HIV infection 3–12 weeks after infection. Given that he was now symptom free with negative syphilis serology and at low risk for acquiring HIV, no further investigations were undertaken. The patient had disposed of the test kit and it was not available for inspection. Unlike oral fluid kits recently licensed in the United States, this kit required a fingerprick and a drop of blood to be applied to a reagent strip. The company claimed ‘‘99.4% accuracy’’ for the kit’s results. From discussion with the patient it seemed that the result displayed by the testing kit evolved over time and had to be read between 3 minutes and 8 minutes after applying the drop of blood. The time dependency of the reaction made the kit liable to be misread. We performed an internet search and found that websites selling the kit were no longer active. Furthermore, a US Federal Trade Commission restraining order had been placed on the kit 2 days before the patient presented to our clinic. As well as finding the company to be in breach of US law by selling the kit in the United States, the Centers for Disease Control and Prevention had tested the accuracy of the kit. ‘‘Results of the testing, based on the package instructions, ‘changed dramatically’ during the 15 minutes that the results were reported. After 3 minutes, 15.4% of the kits gave erroneous readings; after 8 minutes, 29.6% registered inaccurate results; after 15 minutes, 59.3% of the kits gave inaccurate results. Moreover, the kits showed both inaccurate HIV positive results and inaccurate HIV negative results.’’ This case is important because the use of the internet to obtain HIV test kits is likely to increase. One study in California found fairly high levels of interest in instant home HIV tests and it is not difficult to locate kits for HIV testing and other diagnostic services on the internet. A home HIV test kit using oral fluid has been licensed in the United States and a home blood collection and telemedicine system is also available, 5 but these are not available legally in the United Kingdom or Europe. All healthcare professionals involved in counselling and testing patients for HIV should be aware that self taken HIV tests may be inaccurate and confirmatory testing in an appropriate laboratory should be performed before making a diagnosis of HIV infection. Although access problems to sexual health services have rightly engendered innovative approaches to diagnosis and management, there should be a note of caution on using new HIV technologies of rapid testing in nonhealthcare settings and legalisation of home and over the counter HIV testing kits. It is imperative that clinical governance issues are addressed. Medicolegal consequences are important, but of greater significance is the distress to individuals and their partners who are wrongly diagnosed or inappropriately reassured through the use of poorly performing kits.

UK health professionals' attitudes and knowledge regarding Human Papillomavirus (HPV) vaccination: A West Yorkshire Study

The mechanisms of Zika virus-induced neuropathogenesis

Zika virus tropism and pathogenesis: understanding clinical impacts and transmission dynamics

Crim1-, a regulator of developmental organogenesis.

Cataract surgery in patients with nanophthalmos. Author reply.

Zika Virus—A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis

Zika Virus Neuropathogenesis-Research and Understanding

ON STRONG PRODUCT OF GRAPHS

Protective effects of isothiocyanates on blood-CSF barrier disruption induced by oxidative stress.

Molecular and cellular insights into Zika virus-related neuropathies

The emergence of Zika virus and its new clinical syndromes

Flow cytometric analysis of decay‐accelerating factor (CD55) on neutrophils from aplastic anaemia patients

Improvement of Recognition on a Multi-Modal Pattern Discrimination Test

Zika Virus-Induced Microcephaly and Its Possible Molecular Mechanism

Linear photonic frequency discriminator on As₂S₃-ring-on-Ti:LiNbO₃ hybrid platform.

A case of a false positive result on a home HIV test kit obtained on the internet

Advances in anesthesia monitoring.

Hide and Seek: The Interplay Between Zika Virus and the Host Immune Response

Mediastinal infection after cardiac operation. A simple closed technique.

Distinct Replication Kinetics, Cytopathogenicity, and Immune Gene Regulation in Human Microglia Cells Infected with Asian and African Lineages of Zika Virus

Zika virus E protein modulates functions of human brain microvascular endothelial cells and astrocytes: implications on blood-brain barrier properties